Judge OKs landmark class action settlement in LGBTQ fertility lawsuit

Judge OKs landmark class action settlement in LGBTQ fertility lawsuit


A Pride flag is seen held up in a crowd during preparation for a Queer March to the Texas State Capitol on April 15, 2023 in Austin, Texas. People from across Texas rallied together in protest against a slew of anti-LGBTQIA+ and drag bills being proposed among legislators.

Brandon Bell | Getty Images

A federal judge approved a landmark class action settlement this week between Aetna and same-sex couples in New York who alleged the insurance behemoth had discriminated against them and other LGBTQ customers seeking fertility treatment.

Aetna, a subsidiary of CVS Health Corp., reached a deal with the couples in October to begin covering artificial insemination for all of its customers nationally and work toward providing equal access for costly in-vitro fertilization procedures. 

The judge’s sign-off on the settlement marks the first time LGBTQ couples who were previously denied fertility coverage in the U.S. can apply to be reimbursed.

Emma Goidel and her spouse, Ilana Caplan, filed a lawsuit against Aetna in 2021 after the health insurer denied several of their requests for covering their fertility treatments. The couple, who were represented by the National Women’s Law Center, said they spent more than $50,000 out of pocket to conceive their second child.

“LGBTQ+ folks are as deserving of becoming parents as anyone else on this planet,” Goidel said. “I hope that when people can start signing up to be compensated, queer folks who have gone on the journey to become parents and faced barriers from insurance feel that they’re not alone in that.”  

Aetna declined to comment. A spokesperson for CVS Health Corp. previously said the company was pleased to resolve the case and was “committed to providing quality care to all individuals regardless of their sexual orientation or gender identity.”

Thirteen states require insurers to cover fertility treatments for same-sex couples who cannot conceive on their own, according to RESOLVE, a national infertility association. However, the law exempts companies that have self-funded insurance policies, where employers directly pay for employee claims.

“It is really uncomfortable sometimes to talk to your employer or your HR department about what benefits are offered, especially when those benefits have to do with wanting to start a family,” said Allison Tanner, an attorney for the National Women’s Law Center.

Similar cases have been filed against other insurance giants, including UnitedHealthcare and Blue Cross Blue Shield. Those companies did not immediately return requests for comment on Aetna’s settlement.



Source

Inside politics of broken, unaffordable U.S. health care, Cityblock CEO Toyin Ajayi sees opportunity
Health

Inside politics of broken, unaffordable U.S. health care, Cityblock CEO Toyin Ajayi sees opportunity

For the first time in decades, people are having real conversations about health care, “from the ground up,” says Dr. Toyin Ajayi. That has her feeling optimistic. “We’re in a moment where health and health care — and what it means to be healthy — is the subject of a national discussion,” the co-founder and […]

Read More
Il Makiage parent Oddity takes aim at Hims with new telehealth skincare platform Methodiq
Health

Il Makiage parent Oddity takes aim at Hims with new telehealth skincare platform Methodiq

Methodiq brand advertisement. Courtesy: Methodiq Il Makiage parent company Oddity is branching out into medical-grade skin care with its new brand Methodiq, as the online retailer looks to compete with Hims and help to address what it called a “broken medical care system.”  Methodiq, which has been in the works for four years and launched […]

Read More
Novo Nordisk cuts direct-to-consumer prices for Wegovy, Ozempic to 9 a month
Health

Novo Nordisk cuts direct-to-consumer prices for Wegovy, Ozempic to $349 a month

Boxes of Ozempic and Wegovy made by Novo Nordisk at a pharmacy in London on March 8, 2024. Hollie Adams | Reuters Novo Nordisk on Monday said it has cut the direct-to-consumer prices of its blockbuster weight loss drug Wegovy and diabetes counterpart Ozempic, adding to efforts by the company and the Trump administration to […]

Read More